Junpei Soeda

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis.

Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis.

Journal: Gut

Published: July 16, 2023

Hepatic rhythmicity of endoplasmic reticulum stress is disrupted in perinatal and adult mice models of high-fat diet-induced obesity.

Hepatic rhythmicity of endoplasmic reticulum stress is disrupted in perinatal and adult mice models of high-fat diet-induced obesity.

Journal: International journal of food sciences and nutrition

Published: December 01, 2016

Acetylcholine induces fibrogenic effects via M2/M3 acetylcholine receptors in non-alcoholic steatohepatitis and in primary human hepatic stellate cells.

Acetylcholine induces fibrogenic effects via M2/M3 acetylcholine receptors in non-alcoholic steatohepatitis and in primary human hepatic stellate cells.

Journal: Journal of gastroenterology and hepatology

Published: February 18, 2015

Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice.

Maternal obesity programs offspring non-alcoholic fatty liver disease through disruption of 24-h rhythms in mice.

Journal: International journal of obesity (2005)

Published: January 17, 2015

Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis.

Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis.

Journal: Scientific reports

Published: October 03, 2014

Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure.

Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure.

Journal: Journal of hepatology

Published: May 15, 2014

Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms.

Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms.

Journal: PloS one

Published: September 17, 2013

The β-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers through increasing progenitor numbers by Wnt in mice.

The β-adrenoceptor agonist isoproterenol rescues acetaminophen-injured livers through increasing progenitor numbers by Wnt in mice.

Journal: Hepatology (Baltimore, Md.)

Published: September 07, 2013

Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis.

Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis.

Journal: Biochemical and biophysical research communications

Published: June 28, 2013

Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.

Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.

Journal: PloS one

Published: May 21, 2013

Recent advancements in drug treatment of obesity.

Recent advancements in drug treatment of obesity.

Journal: Clinical medicine (London, England)

Published: October 30, 2012

Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice.

Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice.

Journal: Hepatology (Baltimore, Md.)

Published: January 04, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026